SEC Filing Summary: Seneca Biopharma, Inc. (SNCA)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Seneca Biopharma, Inc. on January 23, 2020. The registrant is incorporated in Delaware and its common stock trades on the NASDAQ Capital Market under the symbol "SNCA". The report serves as a Regulation FD disclosure regarding the company's outstanding share count as of the filing date.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only quantitative metric disclosed is the capital structure:
- Common Stock Outstanding: 8,330,720 shares (par value $0.01 per share) as of January 23, 2020.
Material Changes
The filing does not disclose material changes in financial performance or operations compared to prior periods. It solely updates the record of issued and outstanding shares.
Guidance, Outlook, and Risks
The document contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is a procedural disclosure of share count.
Key Facts for Investor Verification
- Verify the current share count of 8,330,720 against subsequent filings to track dilution or buybacks.
- Confirm the trading symbol "SNCA" on the NASDAQ Capital Market.
- Note that this filing explicitly states the information is not "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.